First Trust Advisors LP Quanterix Corp Transaction History

First Trust Advisors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$15.06 - $30.65 $145,825 - $296,783	-9,683 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$23.26 - $42.41 $9,466 - $17,260	-407 Reduced 4.03%	9,683 $283,000
Q4 2021 Feb 08, 2022	SELL	$37.54 - $57.51 $1.76 Million - $2.69 Million	-46,849 Reduced 82.28%	10,090 $428,000
Q3 2021 Nov 15, 2021	SELL	$45.91 - $59.67 $1.12 Million - $1.45 Million	-24,312 Reduced 29.92%	56,939 $2.84 Million
Q2 2021 Aug 16, 2021	SELL	$43.3 - $67.17 $344,538 - $534,471	-7,957 Reduced 8.92%	81,251 $4.77 Million
Q1 2021 May 14, 2021	BUY	$44.11 - $90.64 $965,479 - $1.98 Million	21,888 Added 32.51%	89,208 $5.22 Million
Q4 2020 Feb 02, 2021	BUY	$33.89 - $49.88 $2.28 Million - $3.36 Million	67,320 New	67,320 $3.13 Million

155

33.2M

30.6K

25.1K

Ticker QTRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 36,987,600
Market Cap $436M
Description
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.